Brooklyn Immunotherapeutics Inc.

Brooklyn Immunotherapeutics Inc.

World Rank (Aug-2026)
8971
Market Cap (Aug-2026)
1.063 Billion USD
Market Cap (Mar-08-2026)
1.514 Billion USD
World Rank (Jan-05-2024)
18,926
World Rank (Jul-30-2023)
18,926
World Rank (Jan-07-2022)
18,926
Market Cap (Jan-07-2022)
0.200 Billion USD
Headquarters Country
USA
Headquarters City/State
New York
World Region
Americas
World Subregion
Northern America
Annual Operating Income in USD
-9 Million USD
Annual Net Income in USD
-14 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
6 Million USD
Total Liabilities in USD
3 Million USD
Total Equity in USD
2 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biotechnology
Biopharmaceutical
Company Website
BROOKLYN IMMUNOTHERAPEUTICS, INC.
Company Profile
Brooklyn ImmunoTherapeutics is a Clinical Stage Biopharmaceutical company committed to creating a world where patients and families with high unmet medical needs have access to effective treatments. The company annual revenue is 5.8 million USD. The headquarters is in USA.

Share